A
Ann S. Hashimoto
Researcher at University of Hawaii at Manoa
Publications - 6
Citations - 279
Ann S. Hashimoto is an academic researcher from University of Hawaii at Manoa. The author has contributed to research in topics: Colitis & Colorectal cancer. The author has an hindex of 4, co-authored 5 publications receiving 234 citations.
Papers
More filters
Journal ArticleDOI
Selenoprotein K Knockout Mice Exhibit Deficient Calcium Flux in Immune Cells and Impaired Immune Responses
Saguna Verma,FuKun W. Hoffmann,Mukesh Kumar,Zhi Huang,Kelsey Roe,Elizabeth D. Nguyen-Wu,Ann S. Hashimoto,Peter R. Hoffmann +7 more
TL;DR: The results establish Sel K as an endoplasmic reticulum-membrane protein important for promoting effective Ca2+ flux during immune cell activation and provide insight into molecular mechanisms by which dietary selenium enhances immune responses.
Journal ArticleDOI
Specific antioxidant selenoproteins are induced in the heart during hypertrophy
FuKun W. Hoffmann,Ann S. Hashimoto,Byung Cheon Lee,Aaron H. Rose,Ralph V. Shohet,Peter R. Hoffmann +5 more
TL;DR: The main response of the selenoproteome during hypertrophy does not involve increased GPX1, but increased GPx3 for reducing extracellular H( 2)O(2) and increasedGPx4, Trxrd1, and MsrB1 for minimizing intracellular oxidative damage.
Journal ArticleDOI
Calpastatin Prevents NF-κB–Mediated Hyperactivation of Macrophages and Attenuates Colitis
Zhi Huang,Aaron H. Rose,FuKun W. Hoffmann,Ann S. Hashimoto,Pietro Bertino,Tobias Denk,Jiro Takano,Nobuhisa Iwata,Takaomi C. Saido,Peter R. Hoffmann +9 more
TL;DR: It is found that calpain levels did not differ between intestinal tissues from inflammatory bowel disease (IBD) patients and healthy controls, but IBD tissues showed increased levels of the endogenous calpain inhibitor, calpastatin (CAST).
Journal ArticleDOI
Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer
Aaron H. Rose,Zhi Huang,Chrisy Mafnas,Jared Hara,FuKun W. Hoffmann,Ann S. Hashimoto,Pietro Bertino,Peter R. Hoffmann +7 more
TL;DR: Overall, these findings suggest that intervention with a calpain-2 inhibitor may reduce colitis and colitis-associated cancer through a two-hit process of limiting macrophage activation and inhibiting growth of the colorectal cancer cells themselves.
Journal ArticleDOI
Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme.
Michael P. Marciel,Aaron H. Rose,Verena Martinez,David Horio,Ann S. Hashimoto,FuKun W. Hoffmann,Pietro Bertino,Peter R. Hoffmann +7 more
TL;DR: Five human colon cancer cell lines were directly treated with a calpain‐2 inhibitor and results showed increased cell death in 4 of 5 cell lines and decreased anchorage‐independent growth for all cell five lines, suggesting calpain-2 inhibitor treatment may be most effective on colorectal tumors expressing highest levels of calpain•2.